StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Cash

<< Previous

Bullboard Posts

Next >>

Comment by brad129on Jun 22, 2022 11:03am

158 Views

Post# 34773923

RE:RE:RE:RE:RE:Cash

what ever the mess, simple fact when the bank account hits zero and can no longer pay employees they would be done. Without either financing or sales the account would be zero by now. And so far no financing deal announced.

TrippinAgain123 wrote: Are you new to SZ? It took them 4 years to learn how to put out a quarterly on time. Who knows that kind of mess is happening over their currently. There is a reason the CFO/COO resigned without explanation. We will find out how bad it is soon enough. Please dont make the mistake of grasping onto hope once again.... it will only be more painful.

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?